Aventis Pharma Plans Brand Acquisitions In India Expansion Move
This article was originally published in PharmAsia News
Executive Summary
India's Aventis Pharma plans to acquire branded drugs and expand as part of an effort to be major hub for parent Sanofi-Aventis' research and development and manufacturing. Managing Director Shallesh Ayyangar said he could not say how much the Paris-based company would invest in the India expansion. Sanofi already has two large plants in India, one for active pharmaceutical ingredients. Ayyangar said his unit plans to launch extensions or upgrades of existing drugs and drugs aimed at diabetes, oncology and the central nervous system. Sanofi also is looking at conducting more clinical trials in India. (Click here for more